Retacrit® – a new biosimilar erythropoietin for the treatment of renal and chemotherapy-induced anaemia
Year: 2008; Nr: 5; Pages: 30- 30;- Congresses
- EJHP Journals
- Academy
- News
- Advocacy
- Calendars
- EAHP survey
- General Assemblies
- Hospital Pharmacy
- Useful links
- About
